Comparison of dexmedetomidine and a dexmedetomidine-esketamine combination for reducing dental anxiety in preschool children undergoing dental treatment under general anesthesia: A randomized controlled trial

被引:4
作者
Xing, Fei [1 ,2 ]
Zhang, Tong-Tong [1 ]
Yang, Zhihu [1 ]
Qu, Mingcui [1 ]
Shi, Xiaoshan [1 ]
Li, Yanna [1 ]
Li, Yan [1 ]
Zhang, Wei [1 ,2 ]
Wang, Zhongyu [1 ,2 ,3 ]
Xing, Na [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol Pain & Perioperat Med, Zhengzhou 450052, Henan, Peoples R China
[2] Henan Prov Int Joint Lab Pain Cognit & Emot, Zhengzhou 450052, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol Pain & Perioperat Med, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Esketamine; Dexmedetomidine; Dental anxiety; Emergence agitation; Preschool children; SEVOFLURANE ANESTHESIA; EMERGENCE AGITATION; PREVENTION; SYMPTOMS; KETAMINE; FEAR;
D O I
10.1016/j.jad.2023.12.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Dental anxiety is a widespread complication occurring in pediatric patients during dental visits and may lead to undesirable complications. Esketamine may be effective in anxiety.Objective: The objective of this study was to investigate the effect of premedication with a dexmedetomidineesketamine combination compared with dexmedetomidine alone on dental anxiety in preschool children undergoing dental treatment under general anesthesia.Methods: This is a prospective, double-blinded, randomized controlled trial. A total of 84 patients were scheduled for elective outpatient dental caries treatment under general anesthesia. Patients were randomly premedicated with intranasal dexmedetomidine (group D) or intranasal dexmedetomidine-esketamine (group DS). The primary outcome was the level of dental anxiety assessed by the Modified Child Dental Anxiety Scale (MCDAS) at 2 h after surgery. Secondary outcomes included level of dental anxiety at 1 day and 7 days after surgery, the incidence of dental anxiety at 2 h, 1 day, and 7 days after surgery, sedation onset time, overall success of sedation, acceptance of mask induction, postoperative pain intensity, incidence of emergence agitation in PACU, adverse reactions, HR, and SpO2 before premedication (baseline) and at 10, 20, and 30 min after the end of study drug delivery.Results: The dental anxiety in group DS was lower than that in group D at 2 h, 1 day, and 7 days postoperatively (P = 0.04, 0.004, and 0.006, respectively). The incidences of dental anxiety in group DS were lower than those in group D at 2 h (53 % vs 76 %, P = 0.03), 1 day (47 % vs 71 %, P = 0.04), and 7 days (44 % vs 71 %, P = 0.02) after surgery. Group DS had a higher success rate of sedation (P = 0.03) but showed a lower MAS score (P = 0.005) and smoother hemodynamics (P < 0.01) after drug administration than group D. Group DS showed a significantly lower incidence rate of emergence agitation (P = 0.03) and postoperative pain intensity (P = 0.006) than that in group D during the anesthesia recovery time. The occurrence of adverse reactions was similar in both groups (P > 0.05).Limitations: We did not analyze and correct for the learning effect caused by repeated applications of the MCDAS and MCDAS scores on the 1 day after surgery were obtained by telephone follow-up.Conclusions: Compared to premedication with dexmedetomidine alone, premedication with intranasal dexmedetomidine combined with esketamine could significantly improve dental anxiety in preschool children undergoing dental treatment under general anesthesia.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 39 条
[1]   Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: A pilot study [J].
Akeju, Oluwaseun ;
Hobbs, Lauren E. ;
Gao, Lei ;
Burns, Sara M. ;
Pavone, Kara J. ;
Plummer, George S. ;
Walsh, Elisa C. ;
Houle, Tim T. ;
Kim, Seong-Eun ;
Bianchi, Matt T. ;
Ellenbogen, Jeffrey M. ;
Brown, Emery N. .
CLINICAL NEUROPHYSIOLOGY, 2018, 129 (01) :69-78
[2]   European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium [J].
Aldecoa, Cesar ;
Bettelli, Gabriella ;
Bilotta, Federico ;
Sanders, Robert D. ;
Audisio, Riccardo ;
Borozdina, Anastasia ;
Cherubini, Antonio ;
Jones, Christina ;
Kehlet, Henrik ;
MacLullich, Alasdair ;
Radtke, Finn ;
Riese, Florian ;
Slooter, Arjen J. C. ;
Veyckemans, Francis ;
Kramer, Sylvia ;
Neuner, Bruno ;
Weiss, Bjoern ;
Spies, Claudia D. .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2017, 34 (04) :192-214
[3]   The long-term effect of previous dental treatment under general anaesthesia on children's dental fear and anxiety [J].
Aldossari, Ghadah S. ;
Aldosari, Alanoud A. ;
Alasmari, Amirah A. ;
Aldakheel, Rwan M. ;
Al-Natsha, Reem R. ;
Aldossary, Mohammed S. .
INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2019, 29 (02) :177-184
[4]   Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain [J].
ArendtNielsen, L ;
Nielsen, J ;
PetersenFelix, S ;
Schnider, TW ;
Zbinden, AM .
BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (05) :625-631
[5]   Turkish version of the faces version of the Modified Child Dental Anxiety Scale (MCDASf): translation, reliability, and validity [J].
Arslan, Ipek ;
Aydinoglu, Sema .
CLINICAL ORAL INVESTIGATIONS, 2022, 26 (02) :2031-2042
[6]   DENTAL FEAR AND AVOIDANCE - CAUSES, SYMPTOMS, AND CONSEQUENCES [J].
BERGGREN, U ;
MEYNERT, G .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1984, 109 (02) :247-251
[7]   Dexmedetomidine [J].
Bhana, N ;
Goa, KL ;
McClellan, KJ .
DRUGS, 2000, 59 (02) :263-268
[8]   Facilitating coping behavior in children prior to dental general anesthesia: a randomized controlled trial [J].
Campbell, C ;
Hosey, MT ;
McHugh, S .
PEDIATRIC ANESTHESIA, 2005, 15 (10) :831-838
[9]  
Cantekin K., 2014, PEDIATR DENT, V36, p12E
[10]   Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study [J].
Chen, Sai ;
Yang, Jin-Jin ;
Zhang, Yue ;
Lei, Lei ;
Qiu, Di ;
Lv, Hui-Min ;
Sun, Zhen-Tao ;
Hashimoto, Kenji ;
Yang, Jian-Jun .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024, 274 (04) :767-775